CVS Health Corporation $CVS Stock Sold by Curated Wealth Partners LLC

Key Points

• Curated Wealth Partners cut its CVS Health stake by 94.5% in the third quarter, selling 123,126 shares and retaining 7,150 shares valued at approximately $613,000.
• Despite the sale, institutional investors own 80.66% of CVS, with several major funds—including State Street, Wellington Management and Bank of America—raising their positions. Analysts maintain a broadly positive outlook, with a consensus “Moderate Buy” rating and a $107.80 price target.
• CVS reported stronger-than-expected quarterly results, including $2.58 adjusted EPS and $106.1 billion in revenue, while maintaining a quarterly dividend of $0.665 per share. The company also faces legal and reputational pressure from a $315 million opioid settlement.

Curated Wealth Partners LLC lessened its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 94.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,150 shares of the pharmacy operator's stock after selling 123,126 shares during the quarter. Curated Wealth Partners LLC's holdings in CVS Health were worth $613,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CVS. BlackRock Inc. purchased a new stake in CVS Health in the second quarter valued at $12,747,462,000. State Street Corp boosted its stake in CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator's stock valued at $7,751,205,000 after acquiring an additional 15,604,883 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator's stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of CVS Health by 148.0% during the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator's stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC acquired a new stake in shares of CVS Health during the second quarter worth about $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on CVS shares. Leerink Partners reduced their target price on CVS Health from $119.00 to $112.00 and set an "outperform" rating for the company in a report on Monday. BMO Capital Markets set a $112.00 price target on CVS Health in a research note on Wednesday, September 9th. Robert W. Baird set a $107.00 price target on CVS Health in a research note on Thursday, August 6th. Weiss Ratings lowered CVS Health from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, October 9th. Finally, Piper Sandler set a $112.00 price target on CVS Health in a research report on Wednesday, September 9th. Twenty investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $107.80.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Improving fundamentals and valuation support the stock. CVS has recently exceeded earnings and revenue expectations, while analysts cited stronger returns, rising earnings estimates and a lower valuation than Alignment Healthcare. Its Aetna turnaround is also viewed as a potential catalyst. CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?
• Positive Sentiment: Expanded care access and quality credentials reinforce CVS’s healthcare-services strategy. CVS opened its first pharmacy-focused location in the Boston area to improve access to medications, immunizations and other services. Separately, MinuteClinic received its seventh consecutive Joint Commission accreditation, with primary care available at more than 65% of its locations. CVS Pharmacy Celebrates Opening of First Pharmacy-Focused Location in Boston Area
• Neutral Sentiment: New women’s-health collaboration could support longer-term engagement. CVS is partnering with The Midlife Collective on a research study and documentary focused on women’s midlife health. The initiative may strengthen brand awareness and consumer relationships, but it is unlikely to have a near-term financial impact. CVS Health Collaborates With The Midlife Collective
• Positive Sentiment: Home-based heart monitoring expands value-added services. Signify Health, part of CVS, offers continuous heart-rhythm monitoring for eligible health-plan members, potentially enabling earlier detection of serious conditions and supporting preventive-care economics. CVS Health: Early Detection Matters
• Negative Sentiment: $315 million opioid settlement creates legal, financial and reputational pressure. CVS agreed to settle Justice Department allegations involving unlawful opioid dispensing and false claims. The company admitted no wrongdoing but will implement tighter controlled-substance oversight, adding costs and highlighting compliance risks. CVS Agrees to Pay $315M

CVS Health Trading Up 2.3%

Shares of CVS Health stock opened at $92.45 on Friday. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a market capitalization of $118.25 billion, a P/E ratio of 24.46, a PEG ratio of 0.84 and a beta of 0.60. The company's fifty day moving average is $91.80 and its two-hundred day moving average is $93.03.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be given a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Thursday, October 22nd. CVS Health's dividend payout ratio (DPR) is presently 70.37%.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company's major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.